An update on xenotransplantation

Xenotransplantation is one of the possible avenues currently being explored to address the shortage problem of human organs. With this in mind, this article will briefly review the current situation with respect to the immunological, physiological and biosafety aspects related to the transplantation of pig organs into primates. Acute humoral xenograft rejection (AHXR) currently remains the central immunological obstacle and the development of strategies for both a better control of the elicited anti-pig humoral immune response or the prevention of the onset of coagulation disorders that accompany AHXR are the two primary focuses of research. To date, porcine xenografts have been shown to sustain the life of nonhuman primates for several months. Such preclinical studies have also demonstrated the absence of insurmountable physiological incompatibilities between pig and primate. In addition, reassuring findings regarding biosafety aspects have been generated and pro-active research aimed at the identification of an organ source with a higher safety profile is also underway. These advancements, in conjunction with ongoing research in pig genetic engineering, immunosuppression and tolerance are expected to further extend the survival of porcine xenografts transplanted into primates. However, until further physiological, efficacy and safety data are generated in relevant primate models, clinical xenotransplantation should not be considered.     

Evaluating alternative methods for biophysical and cultural ecosystem services hotspot mapping in natural resource planning

Context

Data for biophysically modeled and Public Participatory GIS (PPGIS)-derived cultural ecosystem services have potential to identify natural resource management synergies and conflicts, but have rarely been combined. Ecosystem service hot/coldspots generated using different methods vary in their spatial extent and connectivity, with important implications.

Objectives

We map biophysically modeled and PPGIS-derived cultural services for six U.S. national forests using six hot/coldspot delineation methods. We evaluate the implications of hotspot methods for management within and outside of designated wilderness areas.

Methods

We used the ARIES and SolVES modeling tools to quantify four biophysically modeled and 11 largely cultural ecosystem services for six national forests in Colorado and Wyoming, USA. We mapped hot/coldspots using two quantile methods (top and bottom 10 and 33 % of values), two area-based methods (top and bottom 10 and 33 % of area), and two statistical methods (Getis-Ord Gi* at α = 0.05 and 0.10 significance level) and compare results within and outside wilderness areas.

Results

Delineation methods vary in their degree of conservatism for hot/coldspot extents and spatial clustering. Hotspots were more common in wilderness areas in national forests near the more densely populated Colorado Front Range, while coldspots were more common in wilderness areas in more urban-distant forests in northwest Wyoming.

Conclusions

Statistical hotspot methods of intermediate conservatism (i.e., Getis-Ord Gi*, α = 0.10 significance) may be most useful for ecosystem service hot/coldspot mapping to inform landscape scale planning. We also found spatially explicit evidence in support of past findings about public attitudes toward wilderness areas.

     

Routes and prevalence of shedding of psittacine beak and feather disease virus.

Psittacine beak and feather disease (PBFD) virus was recovered from the feces and crop washings from various species of psittacine birds diagnosed with PBFD. High concentrations of the virus also could be demonstrated in feather dust collection from a room where 22 birds with active cases of PBFD were being housed. The virions recovered from the feces, crop, and feather dust were confirmed to be PBFD virus by ultrastructural, physical, or antigenic characteristics. Virus recovered from the feather dust and feces hemagglutinated cockatoo erythrocytes. The specificity of the agglutination was confirmed by hemagglutination inhibition, using rabbit antibodies against PBFD virus. During the test period, 26% (8 of 31) of the birds screened were found to be excreting PBFD virus in their feces, and 21% (3 of 14) of crop washings were positive for PBFD virus. Some birds in the sample group had active cases of diarrhea, whereas others had normal-appearing feces. Diarrhea was found to be the only significant indicator of whether a bird was likely to be excreting virus from the digestive tract. These findings suggest that exposure of susceptible birds to PBFD virus may occur from contact with contaminated feather dust, feces, or crop secretions. Viral particles that were morphologically similar to parvovirus (20- to 24 nm-icosahedral nonenveloped virions) also were recovered from feces of some of the birds.     

An Update on Xenotransplantation

Xenotransplantation is one of the possible avenues currently being explored to address the shortage problem of human organs. With this in mind, this article will briefly review the current situation with respect to the immunological, physiological and biosafety aspects related to the transplantation of pig organs into primates.Acute humoral xenograft rejection (AHXR) currently remains the central immunological obstacle and the development of strategies for both a better control of the elicited anti-pig humoral immune response or the prevention of the onset of coagulation disorders that accompany AHXR are the two primary focuses of research. To date, porcine xenografts have been shown to sustain the life of nonhuman primates for several months. Such preclinical studies have also demonstrated the absence of insurmountable physiological incompatibilities between pig and primate. In addition, reassuring findings regarding biosafety aspects have been generated and pro-active research aimed at the identification of an organ source with a higher safety profile is also underway.These advancements, in conjunction with ongoing research in pig genetic engineering, immunosuppression and tolerance are expected to further extend the survival of porcine xenografts transplanted into primates. However, until further physiological, efficacy and safety data are generated in relevant primate models, clinical xenotransplantation should not be considered.